{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T18:24:19Z","timestamp":1775672659985,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Cancer Center Clinical Research in \u201cClimbing\u201d Foundation of China","award":["NCC201818A55"],"award-info":[{"award-number":["NCC201818A55"]}]},{"name":"Natural Science Foundation Health Union Foundation of Hunan Province, China","award":["2021JJ70030"],"award-info":[{"award-number":["2021JJ70030"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-70379-6","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T08:14:20Z","timestamp":1724314460000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Potential utility of ADNP in circulating tumor cells as biomarker for prognostics in non-muscle-invasive bladder cancer"],"prefix":"10.1038","volume":"14","author":[{"given":"Yuheng","family":"Wen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihao","family":"Ming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingji","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangqun","family":"She","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,21]]},"reference":[{"key":"70379_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"70379_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","volume":"81","author":"M Babjuk","year":"2022","unstructured":"Babjuk, M. et al. European association of urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ). Eur. Urol. 81, 75\u201394 (2022).","journal-title":"Eur. Urol."},{"key":"70379_CR3","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1001\/jama.2020.17598","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis, A. T., Lec, P. M., Chamie, K. & Mshs, M. D. Bladder cancer: A review. JAMA 324, 1980\u20131991 (2020).","journal-title":"JAMA"},{"key":"70379_CR4","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1200\/JCO.2014.55.4055","volume":"32","author":"CN Sternberg","year":"2014","unstructured":"Sternberg, C. N. & Apolo, A. B. Everything old is new again! Neoadjuvant chemotherapy in the treatment of muscle-invasive bladder cancer. J. Clin. Oncol. 32, 1868\u20131870 (2014).","journal-title":"J. Clin. Oncol."},{"key":"70379_CR5","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/nrclinonc.2009.44","volume":"6","author":"K Pantel","year":"2009","unstructured":"Pantel, K., Alix-Panabi\u00e8res, C. & Riethdorf, S. Cancer micrometastases. Nat. Rev. Clin. Oncol. 6, 339\u2013351 (2009).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"70379_CR6","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.eururo.2023.03.029","volume":"84","author":"I Jubber","year":"2023","unstructured":"Jubber, I. et al. Epidemiology of bladder cancer in 2023: A systematic review of risk factors. Eur. Urol. 84, 176\u2013190 (2023).","journal-title":"Eur. Urol."},{"key":"70379_CR7","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1200\/JCO.18.02052","volume":"37","author":"E Christensen","year":"2019","unstructured":"Christensen, E. et al. Early detection of metastatic relapse and monitoring of therapeutic efficacy by ultra-deep sequencing of plasma cell-free DNA in patients with urothelial bladder carcinoma. J. Clin. Oncol. 37, 1547\u20131557 (2019).","journal-title":"J. Clin. Oncol."},{"key":"70379_CR8","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.eururo.2017.09.011","volume":"73","author":"K Birkenkamp-Demtr\u00f6der","year":"2018","unstructured":"Birkenkamp-Demtr\u00f6der, K. et al. Monitoring treatment response and metastatic relapse in advanced bladder cancer by liquid biopsy analysis. Eur. Urol. 73, 535\u2013540 (2018).","journal-title":"Eur. Urol."},{"key":"70379_CR9","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3390\/cancers12020353","volume":"12","author":"M Metzenmacher","year":"2020","unstructured":"Metzenmacher, M. et al. Plasma next generation sequencing and droplet digital-qPCR-based quantification of circulating cell-free RNA for noninvasive early detection of cancer. Cancers 12, 353 (2020).","journal-title":"Cancers"},{"key":"70379_CR10","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3322\/caac.21631","volume":"70","author":"VG Patel","year":"2020","unstructured":"Patel, V. G., Oh, W. K. & Galsky, M. D. Treatment of muscle-invasive and advanced bladder cancer in 2020. CA Cancer J. Clin. 70, 404\u2013423 (2020).","journal-title":"CA Cancer J. Clin."},{"key":"70379_CR11","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1016\/S0140-6736(22)01188-6","volume":"400","author":"E Comp\u00e9rat","year":"2022","unstructured":"Comp\u00e9rat, E. et al. Current best practice for bladder cancer: A narrative review of diagnostics and treatments. Lancet (London, England) 400, 1712\u20131721 (2022).","journal-title":"Lancet (London, England)"},{"key":"70379_CR12","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.eururo.2011.06.001","volume":"60","author":"RJ Sylvester","year":"2011","unstructured":"Sylvester, R. J. How well can you actually predict which non-muscle-invasive bladder cancer patients will progress?. Eur. Urol. 60, 431\u2013433 (2011).","journal-title":"Eur. Urol."},{"key":"70379_CR13","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.3390\/cancers12061352","volume":"12","author":"JMY Ko","year":"2020","unstructured":"Ko, J. M. Y. et al. Liquid biopsy serial monitoring of treatment responses and relapse in advanced esophageal squamous cell carcinoma. Cancers 12, 1352 (2020).","journal-title":"Cancers"},{"key":"70379_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.701298","volume":"11","author":"G Fu","year":"2021","unstructured":"Fu, G. et al. Microfluidic assaying of circulating tumor cells and its application in risk stratification of urothelial bladder cancer. Front. Oncol. 11, 701298 (2021).","journal-title":"Front. Oncol."},{"key":"70379_CR15","doi-asserted-by":"publisher","first-page":"5989","DOI":"10.3390\/cancers13235989","volume":"13","author":"MB Morelli","year":"2021","unstructured":"Morelli, M. B. et al. Correlation between high PD-L1 and EMT\/invasive genes expression and reduced recurrence-free survival in blood-circulating tumor cells from patients with non-muscle-invasive bladder cancer. Cancers 13, 5989 (2021).","journal-title":"Cancers"},{"key":"70379_CR16","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1158\/2159-8290.CD-20-1311","volume":"11","author":"C Alix-Panabi\u00e8res","year":"2021","unstructured":"Alix-Panabi\u00e8res, C. & Pantel, K. Liquid biopsy: From discovery to clinical application. Cancer Discov. 11, 858\u2013873 (2021).","journal-title":"Cancer Discov."},{"key":"70379_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0254433","volume":"16","author":"H Jiang","year":"2021","unstructured":"Jiang, H., Gu, X., Zuo, Z., Tian, G. & Liu, J. Prognostic value of circulating tumor cells in patients with bladder cancer: A meta-analysis. PLoS\u00a0One 16, e0254433 (2021).","journal-title":"PLoS\u00a0One"},{"key":"70379_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.urolonc.2018.02.004","volume":"36","author":"R Azevedo","year":"2018","unstructured":"Azevedo, R. et al. Circulating tumor cells in bladder cancer: Emerging technologies and clinical implications foreseeing precision oncology. Urol. Oncol. 36, 221\u2013236 (2018).","journal-title":"Urol. Oncol."},{"key":"70379_CR19","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrurol.2016.224","volume":"14","author":"MA Gorin","year":"2017","unstructured":"Gorin, M. A. et al. Circulating tumour cells as biomarkers of prostate, bladder, and kidney cancer. Nat. Rev. Urol. 14, 90\u201397 (2017).","journal-title":"Nat. Rev. Urol."},{"key":"70379_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3233\/JAD-142490","volume":"45","author":"I Gozes","year":"2015","unstructured":"Gozes, I., Yeheskel, A. & Pasmanik-Chor, M. Activity-dependent neuroprotective protein (ADNP): A case study for highly conserved chordata-specific genes shaping the brain and mutated in cancer. J. Alzheimer\u2019s Dis. 45, 57\u201373 (2015).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"70379_CR21","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.pharmthera.2007.01.004","volume":"114","author":"I Gozes","year":"2007","unstructured":"Gozes, I. Activity-dependent neuroprotective protein: From gene to drug candidate. Pharmacol. Ther. 114, 146\u2013154 (2007).","journal-title":"Pharmacol. Ther."},{"key":"70379_CR22","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1074\/jbc.M007416200","volume":"276","author":"R Zamostiano","year":"2001","unstructured":"Zamostiano, R. et al. Cloning and characterization of the human activity-dependent neuroprotective protein. J. Biol. Chem. 276, 708\u2013714 (2001).","journal-title":"J. Biol. Chem."},{"key":"70379_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.491129","volume":"10","author":"S Zhu","year":"2020","unstructured":"Zhu, S. et al. ADNP upregulation promotes bladder cancer cell proliferation via the AKT pathway. Front. Oncol. 10, 491129 (2020).","journal-title":"Front. Oncol."},{"key":"70379_CR24","doi-asserted-by":"publisher","first-page":"5114","DOI":"10.7150\/jca.58049","volume":"12","author":"Y Xie","year":"2021","unstructured":"Xie, Y. et al. ADNP prompts the cisplatin-resistance of bladder cancer via TGF-\u03b2-mediated epithelial\u2013mesenchymal transition (EMT) pathway. J. Cancer 12, 5114\u20135124 (2021).","journal-title":"J. Cancer"},{"key":"70379_CR25","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41568-020-00313-1","volume":"21","author":"L Tran","year":"2021","unstructured":"Tran, L., Xiao, J. F., Agarwal, N., Duex, J. E. & Theodorescu, D. Advances in bladder cancer biology and therapy. Nat. Rev. Cancer 21, 104\u2013121 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"70379_CR26","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.3390\/ijms21093360","volume":"21","author":"M Matuszczak","year":"2020","unstructured":"Matuszczak, M. & Salagierski, M. Diagnostic and prognostic potential of biomarkers CYFRA 21.1, ERCC1, p53, FGFR3 and TATI in bladder cancers. Int. J. Mol. Sci. 21, 3360 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"70379_CR27","doi-asserted-by":"publisher","first-page":"8597","DOI":"10.3390\/ijms23158597","volume":"23","author":"M Matuszczak","year":"2022","unstructured":"Matuszczak, M., Kilja\u0144czyk, A. & Salagierski, M. A liquid biopsy in bladder cancer\u2014The current landscape in urinary biomarkers. Int. J. Mol. Sci. 23, 8597 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"70379_CR28","first-page":"3455","volume":"53","author":"JE Hardingham","year":"1993","unstructured":"Hardingham, J. E. et al. Immunobead-PCR: A technique for the detection of circulating tumor cells using immunomagnetic beads and the polymerase chain reaction. Cancer Res. 53, 3455\u20133458 (1993).","journal-title":"Cancer Res."},{"key":"70379_CR29","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1007\/s00109-004-0590-8","volume":"82","author":"J Guo","year":"2004","unstructured":"Guo, J. et al. Combined use of positive and negative immunomagnetic isolation followed by real-time RT-PCR for detection of the circulating tumor cells in patients with colorectal cancers. J. Mol. Med. (Berlin, Germany) 82, 768\u2013774 (2004).","journal-title":"J. Mol. Med. (Berlin, Germany)"},{"key":"70379_CR30","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.3390\/ijms17081264","volume":"17","author":"Y Ma","year":"2016","unstructured":"Ma, Y. et al. Droplet digital PCR based androgen receptor variant 7 (AR-V7) detection from prostate cancer patient blood biopsies. Int. J. Mol. Sci. 17, 1264 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"70379_CR31","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1159\/000258695","volume":"17","author":"M Braitch","year":"2010","unstructured":"Braitch, M. et al. Expression of activity-dependent neuroprotective protein in the immune system: Possible functions and relevance to multiple sclerosis. Neuroimmunomodulation 17, 120\u2013125 (2010).","journal-title":"Neuroimmunomodulation"},{"key":"70379_CR32","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","volume":"388","author":"AM Kamat","year":"2016","unstructured":"Kamat, A. M. et al. Bladder cancer. Lancet (London, England) 388, 2796\u20132810 (2016).","journal-title":"Lancet (London, England)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70379-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70379-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70379-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T04:04:29Z","timestamp":1724472269000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70379-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,21]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["70379"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-70379-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4009102\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,21]]},"assertion":[{"value":"3 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19352"}}